Rhythm Pharmaceuticals Inc RYTM:NASDAQ

Last Price$26.45Cboe Closing Price as of 3:59PM ET 8/15/22
Cboe Real-Time Quotes
Today's Change+4.65(21.33%)
Bid (Size)$24.42 (100)
Ask (Size)$28.19 (100)
Day Low / High$21.26 - 27.29
Volume1.8 M

Rhythm Pharmaceuticals Gets European Commission Approval for Expansion of Imcivree Dosing Regimen

8:39AM ET 6/22/2022 MT Newswires
Rhythm Pharmaceuticals (RYTM) said Wednesday the European Commission approved the expansion of the dosing regimen for its Imcivree drug.

The approval allows for dosing of Imcivree, or setmelanotide, in patients aged 6 years and older who have pro-opiomelanocortin or leptin receptor deficiency and kidney disease. The EC approved the drug last year for the treatment of obesity and hunger control.

The drugmaker said Imcivree is now available in Germany.

Rhythm Pharmaceuticals shares were down 1.4% in recent premarket trading Wednesday.

Price: 4.14, Change: -0.06, Percent Change: -1.43